IL6 and cancer: CAFs in esophageal cancer secrete IL-6, IL-8, CCL5, CXCL1, and TGF-β, leading to the activation of signaling pathways such as Akt, STAT3, ERK1/2, and NF-κB, which affect cancer cell survival, proliferation, and migration.